Reyedar
PrivateLast Round
Grant
Jun 28, 2024
Total Funding Raised
$4.13M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Reyedar is a healthtech company that develops AI-powered eye-tracking diagnostic tools for the early detection of degenerative retinal and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Medical Imaging, Sensors, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reyedar Comparables
Compare Reyedar with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bulbitech | 87% | |
| machineMD | 84% | |
| neuroClues | 83% | |
Reyedar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 28, 2024 | ||||
| Seed | Jul 5, 2023 | ||||
| Seed | Nov 5, 2020 |
Key People
Founding team and executive leadership
Reyedar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blue Sparrows MedTech Fund | Seed |
| University Medical Center Groningen | Grant |
| Cottonwood Technology Fund | Seed |
| UNETI | Seed |
| NOM (Investment and Development Company for the Northern Netherlands) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 4420% MoM, reaching 904.
- Nov 25, 2025
Added Glenn Mullin from Academia/Research as a customer.
Reyedar Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reyedar's valuation, stock price, and market status.